Development and validation of reversed phase high performance liquid chromatography (RP-HPLC) for quantification of captopril in rabbit plasma

• Autorzy: Rasool Muhammad Fawad , Qureshi Umbreen Fatima , Ranjha Nazar Muhammad , Imran Imran , Nisa Mouqadus Un , Majeed Abdul

Identyfikatory

DOI

10.1556/1326.2020.00816

• Języki publikacji: EN

Abstrakty

EN

Th accurate rapid, simple and selective reversed phase high performance liquid chromatography (RPHPLC) has been established and validated for the determination of captopril (CAP). Chromatographic separation was accomplished using prepacked ODSI C18 column (250 mm 3 4.6 mm with 5 mm particle size) in isocratic mode, with mobile phase consisting of water: acetonitrile (60:40 v/v), pH adjusted to 2.5 by using 85% orthophosphoric acid at a flow rate of 1 mL/min and UV detection was performed at 203 nm. RP-HPLC method used for the analysis of CAP in mobile phase and rabbit plasma was established and validated as per ICH-guidelines. It was carried out on a well-defined chromatographic peak of CAP was established with a retention time of 4.9 min and tailing factor of 1.871. The liquid–liquid extraction method was used for extraction of CAP from the plasma. Excellent linearity (R² = 0.999) was shown over range 3.125–100 mg/mL with mean percentage recoveries ranges from 97 to 100.6%. Parameters of precision and accuracy of the developed method meet the established criteria. Intra and inter-day precision (% relative standard deviation) study was also performed which was less than 2% which indicate good reproducibility of the method. The limit of detection (LOD) and quantification for the CAP in plasma were 3.10 and 9.13 ng/mL respectively. The method was suitably validated and successfully applied to the determination of CAP in rabbit plasma samples.

Słowa kluczowe

EN

CAP; RP-HPLC; validation; plasma; system suitability

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2021
• Tom: Vol. 33, no. 4
• Strony: 315--321
• Opis fizyczny: Bibliogr. 32 poz., rys., tab.

Twórcy

autor

Rasool Muhammad Fawad

• Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, 60800, Multan, Pakistan

autor

Qureshi Umbreen Fatima

• Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, 60800, Multan, Pakistan

autor

Ranjha Nazar Muhammad

• Department of Pharmacy, University of Lahore, Gujrat Campus GT Road, Gujrat, Pakistan

autor

Imran Imran

• Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, 60800, Multan, Pakistan

autor

Nisa Mouqadus Un

• Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, 60800, Multan, Pakistan

autor

Majeed Abdul

• Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, 60800, Multan, Pakistan

• https://orcid.org/0000-0002-6711-0832

Bibliografia

• 1 Sultana, N.; Arayne, M. S.; Naveed, S. Chin. Chem. Soc.-Taip. 2010, 57(1), 62–7.
• 2 Ivanovic, D.; Medenica, M.; Malenovic, A.; Jancic, B. Accredit. Qual. Assur. 2004, 9(1–2), 76–81.
• 3 Gadad, A. P.; Reddy, A. D.; Dandagi, P. M.; Masthiholimath, V. S. Asian J. Pharm., 2014, 6(2), 137–43.
• 4 Chikukwa, M. T.; Walker, R. B.; Khamanga, S. M. Pharmaceutics 2020, 12(8), 712.
• 5. Poulin, P.; Theil, F. P. J. Pharm. Sci. 2002, 91(1), 129–56.
• 6 Matsuki, Y.; Fukuhara, K.; Ito, T.; Ono, H.; Ohara, N.; Yui, T.; Nambara, T. J. Chromatogr. A 1980, 188(1), 177–83.
• 7 Funke, P. T.; Ivashkiv, E.; Malley, M. F.; Cohen, A. I. Anal. Chem. 1980, 52(7), 1086–9.
• 8 Franklin, M.; Addison, R.; Baker, P.; Hooper, W. Biomed. Appl. 1998, 705(1), 47–54.
• 9 Shimada, K.; Tanaka, M.; Nambara, T.; Imai, Y.; Abe, K.; Yoshinaga, K. Biomed. Appl. 1982, 227(2), 445–51.
• 10 Bahmaei, M.; Khosravi, A.; Zamiri, C.; Massoumi, A.; Mahmoudian, M. J. Pharmaceut. Biomed. 1997, 15(8), 1181–6.
• 11 Jarrott, B.; Anderson, A.; Hooper, R.; Louis, W. J. Pharm. Sci. 1981, 70(6), 665–7.
• 12 Pereira, C.; Tam, Y.; Collins-Nakai, R.; Ng, P. J. Chromatogr. 1988, 425(1), 208–13.
• 13 Hayashi, K.; Miyamoto, M.; Sekine, Y. J. Chromatogr. B: Biomed. Appl. 1985, 338, 161–9.
• 14 Klein, J.; Colin, P.; Scherer, E.; Levy, M.; Koren, G. Ther. Drug Monit. 1990, 12(1), 105–10.
• 15. Khedr, A.; El-Sherief, H. Biomed. Chromatogr. 1998, 12(2), 57–60.
• 16 Salem, I. I.; Saif, W. A.; Jmeian, Y.; Al Tamimi, J. I. J. Pharmaceut. Biomed. 37(5), 2005, 1073–80.
• 17 Pérez‐Ruiz, T.; Martínez‐Lozano, C.; Galera, R. Electrophoresis 27(12), 2006, 2310–2316.
• 18 Pérez‐Ruiz, T.; Martínez‐Lozano, C.; Sanz, A.; Galera, R. Electrophoresis 2005, 26(12), 2384–2390.
• 19 Muhammad Ranjha, N.; Majeed, A.; Hussain, I.; Fawad Rasool, M. Curr. Pharm. Anal. 2017, 13(5), 446–51.
• 20 Ayad, M. M.; Hosny, M. M.; Ibrahim, A. E.; El-Abassy, O. M.; Belal, F. F. Acta Chromatogr. 2020, 1–6.
• 21 Abbas, G.; Saadullah, M.; Rasul, A.; Shah, S.; Khan, S. M.; Hanif, M.; Masood Ahmed, M. Acta Chromatogr. 2020, 32(3), 157–65.
• 22. Zuo, Y. High-performance liquid chromatography (HPLC): Principles, practices and procedures. Nova Science Publishers, Incorporated; 2014.
• 23. Zuo, Y.; Wang, C.; J. Zhou; Sachdeva, A.; Ruelos, V. C. Anal. Sci. 2008, 24(12), 1589–92.
• 24. Zuo, R.; Zhou, S.; Zuo, Y.; Deng, Y. Food Chem. 2015, 182 242–5.
• 25. Zhou, S.; Zuo, R.; Zhu, Z.; Wu, D.; Vasa, K.; Deng, Y.; Zuo, Y. Anal. Methods 2013, 5(5), 1307–11.
• 26. Guideline, I. H. T. In Validation of analytical procedures: text and methodology Q2 (R1); International Conference on Harmonization, Geneva, Switzerland; 2005.
• 27 Tran, Q. H.; Nguyen, T. T.; Pham, K. P. Int. J. Anal. Chem. 2020, 2020.
• 28. Surve, D. H.; Jindal, A. B. J. Pharmaceut. Biomed. 2019, 175, 112765.
• 29 Syed, H. K.; Liew, K. B.; Loh, G. O. K.; Peh, K. K. Food Chem. 2015, 170 321–6.
• 30 Sultana, N.; Arayne, M. S.; Naveed, S. J. Chin. Chem. Soc.-Taip. 2010, 57(3A), 378–83.
• 31 Banoglu, E.; €Ozkan, Y.; Atay, O. Il Farmaco 2000, 55(6–7), 477–83.
• 32 Huang, T.; He, Z.; Yang, B.; Shao, L.; Zheng, X.; Duan, G. J. Pharmaceut. Biomed. 2006, 41(2), 644–8.